27 research outputs found
Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care
Background Post percutaneous coronary intervention (PCI) fractional flow reserve (FFR) is a significant predictor of
major adverse cardiac events (MACE). The rationale for low post procedural FFR values often remains elusive based on
angiographic findings alone, warranting further assessment using an FFR pullback or additional intravascular imaging. It is
currently unknown if additional interventions intended to improve the PCI, decrease MACE rates.
Study design The FFR REACT trial is a prospective, single-center randomized controlled trial in which 290 patients with
a post PCI FFR b0.90 will be randomized (1:1) to either standard of care (no additional intervention) or intravascular
ultrasound (IVUS)-directed optimization of the FFR (treatment arm). Eligible patients are those treated with angiographically
successful PCI for (un)stable angina or non-ST elevation myocardial infarction (MI). Assuming 45% of patients will have a post
PCI FFR b0.90, approximately 640 patients undergoing PCI will need to be enrolled. Patients with a post PCI FFR ≥ 0.90 will
be enrolled in a prospective registry. The primary end point is defined as a composite of cardiac death, target vessel MI and
clinically driven target vessel revascularisation (target vessel failure) at 1 year. Secondary end points will consist of individual
components of the primary end point, procedural success, stent thrombosis and correlations on clinical outcome, changes in
post PCI Pd/Pa and FFR and IVUS derived dimensions. All patients will be followed for 3 years.
Conclusion The FFR-REACT trial is designed to explore the potential benefit of HD-IVUS-guided PCI optimization in
patients with a post PCI FFR b0.90 (Dutch trial register: NTR6711). (Am Heart J 2019;213:66-72.
Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis
Objective and background: The study aim is to provide long-term clinical outcome after percutaneous coronary intervention (PCI) for unprotected left main coronary arteries (ULMCA) stenosis with the first-generation (1st-gen) drug-eluting stents (DES) in comparison to 2nd-gen DES, since t
Coronary Physiology: Advancements in technology and post procedural use
In brief the aims of this thesis were: 1. to validate a novel generic non-hyperemic diastolic index (dPR). 2. to validate a wireless non hyperemic angiography based FFR technology (vessel FFR, vFFR) and 3. to assess the distribution of post stenting physiologic indices (FFR, dPR and vFFR) and their association with clinical outcome
Coronary Physiology: Advancements in technology and post procedural use
In brief the aims of this thesis were:
1. to validate a novel generic non-hyperemic diastolic index (dPR).
2. to validate a wireless non hyperemic angiography based FFR technology (vessel FFR, vFFR) and
3. to assess the distribution of post stenting physiologic indices (FFR, dPR and vFFR) and their association with clinical outcome